Результаты поиска - Martina Dameri

  • Отображение 1 - 5 результаты of 5
Отмена результатов
Список   Сетка  
  1. 1

    Comprehensive analysis of plasma methylome reveals distinct patterns of methylation changes between responders and non-responders to neoadjuvant chemotherapy in breast cancer по Francesco Ravera, Martina Dameri, Pier Vitale Nuzzo, Mario Stabile, Piero Fregatti, Alberto Ballestrero, Lorenzo Ferrando, Gabriele Zoppoli

    Опубликовано 2024-12-01
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2

    Development of a hoRizontal data intEgration classifier for NOn-invasive early diAgnosis of breasT cancEr: the RENOVATE study protocol по Gabriele Zoppoli, Alberto Ballestrero, Valerio Gaetano Vellone, Piero Fregatti, Francesco Ravera, Gabriella Cirmena, Martina Dameri, Maurizio Gallo, Daniele Friedman, Massimo Calabrese, Alberto Tagliafico, Lorenzo Ferrando

    Опубликовано 2021-12-01
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3

    Liquid biopsy in breast cancer: Redefining precision medicine по Maria Luisa Schiavone, Rosa Scarpitta, Francesco Ravera, Sara Bleve, Carolina Reduzzi, Federico Di Cocco, Martina Dameri, Gabriele Zoppoli, Antonio Giuseppe Naccarato, Pier Vitale Nuzzo, Massimo Cristofanilli, Giuseppe Nicolò Fanelli, Cristian Scatena

    Опубликовано 2025-09-01
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4

    Incidence and immunomic features of apyretic COVID-19 in patients affected by solid tumors: a prospective cohort study по Francesco Ravera, Roberto Borea, Gabriella Cirmena, Martina Dameri, Lorenzo Ferrando, Maurizio Gallo, Cecilia Casini, Neri Fallani, Mario Stabile, Valentina Barbero, Roberto Murialdo, Lucia Tixi, Margherita Cappuccio, Andrea Cuboni, Irene Sivieri, Giuseppe Fornarini, Andrea De Maria, Alberto Ballestrero, Gabriele Zoppoli

    Опубликовано 2022-05-01
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5

    ESR1 gene amplification and MAP3K mutations are selected during adjuvant endocrine therapies in relapsing Hormone Receptor-positive, HER2-negative breast cancer (HR+ HER2- BC). по Lorenzo Ferrando, Andrea Vingiani, Anna Garuti, Claudio Vernieri, Antonino Belfiore, Luca Agnelli, Gianpaolo Dagrada, Diana Ivanoiu, Giuseppina Bonizzi, Elisabetta Munzone, Luana Lippolis, Martina Dameri, Francesco Ravera, Francesco Ravera, Marco Colleoni, Giuseppe Viale, Luca Magnani, Alberto Ballestrero, Gabriele Zoppoli, Giancarlo Pruneri

    Опубликовано 2023-01-01
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: